Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Glaxosmithkline Plc LSE:GSK London Ordinary Share GB0009252882 ORD 25P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -27.60 -1.98% 1,366.00 1,371.00 1,371.60 1,393.60 1,368.60 1,391.80 13,102,741 16:35:26
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 33,754.0 6,221.0 93.9 14.5 68,537

Glaxosmithkline Share Discussion Threads

Showing 19201 to 19223 of 23000 messages
Chat Pages: Latest  776  775  774  773  772  771  770  769  768  767  766  765  Older
DateSubjectAuthorDiscuss
15/2/2019
14:26
Looking very good. Hopefully through 1600p next week :-)
philanderer
15/2/2019
11:42
My other core pharmaceutical holding AZN gave the sector a timely jab.
patientcapital
15/2/2019
11:40
So much for the relentless drip drip drip of negativity!
grahamite2
15/2/2019
11:28
Wow …. climbing well - sustained for longer than I expected this week ….. ;0)
tradermichael
15/2/2019
11:06
I've had Monty on filter for as long as I can remember but I bet he is still bleating on about GSK being a bond.
romeike
15/2/2019
10:09
SOLD 2106 @ 1577.20
tradermichael
14/2/2019
22:31
IC.....don't make me laugh
zicopele
14/2/2019
20:40
Tipped in IC tonight I understand
ayl30
14/2/2019
19:33
It happens Graham. Ten years ago on a CFD I accidentally bought £1m of gold on margin of 1%. I could have lost my shirt.
zicopele
14/2/2019
17:50
Who's for a tripple top at 1620 - good short from there?
toffeeman
14/2/2019
15:14
Me too. I've been badly underwater most of the time but it came right in the end and meanwhile there have been the dividends. I actually sold at 17 and bought back at 16, so at first I felt rather smug that come what may I couldn't have done the wrong thing. Then I realized I had bought 3 times as many as I sold so actually I was exposed.
grahamite2
14/2/2019
14:10
I like GSK dividend, but not increased for 4 years, thats why GSK ord shares like a bond for me.
montyhedge
14/2/2019
14:09
Wasn't that long ago when you were banging on about GSK's div Monty ..change like the weather :)
badtime
14/2/2019
12:16
Astra amazing results, their dividend won't be the same, like GSK has been for the last 4 years, 80p.
montyhedge
14/2/2019
11:55
"Anyone who examines the incidence of failure of drugs in phase three clinical trials knows that even after 10-15 years of development,a drug can come to nought in the latter stages.Patent protection is key to new drug development.If you don’t want new drugs,then fine just allow governments to radically reduce the return on capital by interfering in the current system" Indeed. Spot on. Apparently each drug costs up to £1bn to develop and take through to phase 3 trials where even then they often fail on the efficacy front. Expensive. Patents there to ensure drug companies recoup their losses on the 8-9/10 that never pass phase 3.
wbecki
14/2/2019
11:55
What GSK would give for AZN results which are quite spectacular.
zicopele
14/2/2019
02:10
A dilemma for all governments wishing to control cost of healthcare.Both democrats and republicans are increasingly favouring the increased use of generics as soon as proprietary patents expire but there’s nothing new here.Anyone who examines the incidence of failure of drugs in phase three clinical trials knows that even after 10-15 years of development,a drug can come to nought in the latter stages.Patent protection is key to new drug development.If you don’t want new drugs,then fine just allow governments to radically reduce the return on capital by interfering in the current system.In some instances,the amount charged for certain medication is morally indefensible but such instances are not widespread and are normally “shamed” in the media.Drug companies will be making a very good return on capital for the foreseeable future. Where drug companies are open to criticism was adroitly identified by Hilary Clinton.Drug companies might spend 25% odd of turnover on R&D but they also spend a considerable amount of money on marketing including “jollies”; for the medical profession,bribery of sorts.This is the sort of exercise which should be penalised.
steeplejack
13/2/2019
18:06
There's a detailed SA article on their main oncology compound for anyone interested. It's above my pay grade, just about understand the concept.
essentialinvestor
13/2/2019
16:29
Yes clamp down coming, margins squeezed.
montyhedge
13/2/2019
16:24
Americans pay 180 percent of what Europeans, Canadians, and Japanese pay for the exact same drugs! Our seniors aren't going to foot the bill for free-riders abroad any longer, HHS Secretary Alex Azar says. pic.twitter.com/Zj3Bk8lsdE
wbecki
13/2/2019
15:55
Sold GSK 1560p pick up at 1465p after ex div, piled into IAG (British Airways) no stamp duty only three stocks in FTSE 100 no stamp duty.
montyhedge
13/2/2019
15:52
GSK can now spend the time spent on Advair on shingles.
abdullla
13/2/2019
15:49
You always plan for success. ;)
alphorn
Chat Pages: Latest  776  775  774  773  772  771  770  769  768  767  766  765  Older
ADVFN Advertorial
Your Recent History
LSE
GSK
Glaxosmith..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20201123 22:34:26